{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T02:40:16Z","timestamp":1714617616599},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMW - Fortschritte der Medizin"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s15006-012-1343-1","type":"journal-article","created":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T05:00:33Z","timestamp":1353992433000},"page":"45-47","source":"Crossref","is-referenced-by-count":0,"title":["Krummer Penis macht Sex zur Qual"],"prefix":"10.1007","volume":"154","author":[{"given":"Karsten","family":"Knobloch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,28]]},"reference":[{"key":"1343_CR1","first-page":"425","volume":"1","author":"F Peyronie De La","year":"1743","unstructured":"De La Peyronie F. Sur Quelques obstacles qui soppoent a lejaculation naturelle de la semance. Med Aca R Chir 1743;1:425.","journal-title":"Med Aca R Chir"},{"key":"1343_CR2","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01781.x","volume":"7","author":"D Ralph","year":"2010","unstructured":"Ralph D, et al. The management of Peyronie\u2019s disease: evidence-based 2010 guidelines. J Sex Med 2010;7:2359\u201374.","journal-title":"J Sex Med"},{"issue":"4","key":"1343_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrurol.2010.24","volume":"7","author":"NF Gonzalez-Cadavid","year":"2010","unstructured":"Gonzalez-Cadavid NF, Rajfer J. Treatment of Peyronie\u2019s disease with PDE5 inhibitors: an antifibrotic strategy. Nat Rev Urol 2010;7(4):215\u201321.","journal-title":"Nat Rev Urol"},{"key":"1343_CR4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","volume":"88","author":"U Schwarzer","year":"2001","unstructured":"Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie\u2019s disease: results of a large survey. BJU Int 2001;88:727\u201330.","journal-title":"BJU Int"},{"key":"1343_CR5","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","volume":"171","author":"JP Mulhall","year":"2004","unstructured":"Mulhall JP, Creecj SD, Bpprijan SA et al. Subjective and objective analysis of the prevalence of Peyronie\u2019s disease in a population of men presenting for prostate cancer screening. J Urol 2004;171:2350\u20133.","journal-title":"J Urol"},{"key":"1343_CR6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/sj.ijir.3901247","volume":"16","author":"A Kadioglu","year":"2004","unstructured":"Kadioglu A, Oktar T, Kandirali E, et al. Incidentally diagnosed Peyronie\u2019s disease in men presenting with erectile dysfunction. Int J Impot Res 2004;16:540\u20133.","journal-title":"Int J Impot Res"},{"key":"1343_CR7","first-page":"28503","volume":"2011","author":"DB Dibinedetti","year":"2011","unstructured":"Dibinedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X. A population-based study of Peyronie\u2019s disease: prevalence and treatment patterns in the United States. Adv Urol 2011;2011:28503.","journal-title":"Adv Urol"},{"issue":"1","key":"1343_CR8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1743-6109.2011.02502.x","volume":"9","author":"R Tal","year":"2012","unstructured":"Tal R, Hall MS, Alex B, Choi J, Mulhall JP. Peyronie\u2019s disease in teenagers. J Sex Med 2012;9(1):302\u20138.","journal-title":"J Sex Med"},{"issue":"4","key":"1343_CR9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ijir.2011.18","volume":"23","author":"HM Nugteren","year":"2011","unstructured":"Nugteren HM, Nijman JM, de Jong IJ, van Driel MF. The association between Peyronie\u2019s and Dupuytren\u2019s disease. Int J Impot Res 2011;23(4):142\u20135.","journal-title":"Int J Impot Res"},{"issue":"4Pt1","key":"1343_CR10","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1743-6109.2009.01584.x","volume":"7","author":"EL Rhoden","year":"2010","unstructured":"Rhoden EL, Riedner CE, Fuchs SC, Ribeiro EP, Halmenschlager G. A cross-sectional study for the analysis of clinical, sexual and laboratory conditions to Peyronie\u2019s disease. J Sex Med 2010;7(4 Pt 1):1529\u201337.","journal-title":"J Sex Med"},{"issue":"2","key":"1343_CR11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.urology.2004.04.006","volume":"64","author":"A Qian","year":"2004","unstructured":"Qian A, Meals RA, Rajfer J, Gonzalez-Cadavid NF. Comparison of gene expression profiles between Peyronie\u2019s disease and Dupuytren\u2019s contracture. Urology 2004;64(2):399\u2013404.","journal-title":"Urology"},{"issue":"5","key":"1343_CR12","first-page":"263","volume":"104","author":"T Klotz","year":"2007","unstructured":"Klotz T, Mathers MJ, Sommer F. Induratio penis plastica-eine verschwiegene Erkrankung. Dtsch Arztebl 2007;104(5):A 263\u20137.","journal-title":"Dtsch Arztebl"},{"key":"1343_CR13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/01.ju.0000097498.34847.7c","volume":"171","author":"MF Usta","year":"2004","unstructured":"Usta MF, Bivalacque TJ, Jabren GW, et al. Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie\u2019s disease. J Urol 2004;171:775\u20139.","journal-title":"J Urol"},{"key":"1343_CR14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/j.1939-4640.2000.tb03387.x","volume":"21","author":"WJ Hellstrom","year":"2000","unstructured":"Hellstrom WJ, Bivalacqua TJ. Peyronie\u2019s disease: etiology, medical and surgical therapy. J Androl 2000;21:347\u201354.","journal-title":"J Androl"},{"key":"1343_CR15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.ijir.3900877","volume":"14","author":"JP Pryor","year":"2002","unstructured":"Pryor JP, Ralph DJ. Clinical presentations of Peyronie\u2019s disease. Int J Impot Res 2002;14:414\u20137.","journal-title":"Int J Impot Res"},{"issue":"Suppl5","key":"1343_CR16","first-page":"568","volume":"14","author":"R Shabsigh","year":"2003","unstructured":"Shabsigh R, Fleming M, Pereman M, Anastasiadis A. Peyronie\u2019s disease index (PDI):a standardized patients questionaire. Int J Impot Res 2003;14(Suppl 5):568.","journal-title":"Int J Impot Res"},{"issue":"1","key":"1343_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ijir.2011.45","volume":"24","author":"SM Larsen","year":"2012","unstructured":"Larsen SM, Levine LA. Review of non-surgical treatment options for Peyronie\u2019s disease. Int J Impot Res 2012;24(1):1\u201310.","journal-title":"Int J Impot Res"},{"issue":"5","key":"1343_CR18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/ijir.2010.20","volume":"22","author":"MR Safarinejad","year":"2010","unstructured":"Safarinejad MR. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie\u2019s disease: a double-blind, placebo-controlled randomized study. Int J Impot Res 2010;22(5):298\u2013309.","journal-title":"Int J Impot Res"},{"issue":"1","key":"1343_CR19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1464-410x.2001.02241.x","volume":"88","author":"G Biagiotti","year":"2001","unstructured":"Biagiotti G, Cavallini G. Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie\u2019s disease: a preliminary report. BJU Int 2001;88(1):63\u20137.","journal-title":"BJU Int"},{"issue":"2","key":"1343_CR20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eururo.2009.05.012","volume":"56","author":"A Palmieri","year":"2009","unstructured":"Palmieri A, Imbimbo C, Longo N, Fusco F, Verze P, Mangiapia F, Creta M, Mirone V. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie\u2019s disease. Eur Urol 2009;56(2):363\u20139.","journal-title":"Eur Urol"},{"issue":"2","key":"1343_CR21","first-page":"128","volume":"82","author":"E Berardinis De","year":"2010","unstructured":"De Berardinis E, Busetto GM, Antonini G, Giovannone R, Gentile V. Extracorporeal shock wave therapy in the treatment of Peyronie\u2019s disease: long-term results. Arch Ital Urol Androl 2010;82(2):128\u201333.","journal-title":"Arch Ital Urol Androl"},{"key":"1343_CR22","doi-asserted-by":"crossref","unstructured":"Palmieri A, Imbimbo C, Creta M, Verze P, Fusco F, Mirone V. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie\u2019s disease and erectile dysfunction: results from a prospective randomized trial. Int J Androl 2011 Nov 15.","DOI":"10.1111\/j.1365-2605.2011.01226.x"},{"issue":"5","key":"1343_CR23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.ijir.3900874","volume":"14","author":"JP Mulhall","year":"2002","unstructured":"Mulhall JP, Anderson MS, Lubrano T, Shankey TV. Peyronie\u2019s disease cell culture models: phenotypic, genotypic and functional analyses. Int J Impot Res 2002;14(5):397\u2013405.","journal-title":"Int J Impot Res"},{"issue":"2","key":"1343_CR24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0022-5347(05)64691-5","volume":"168","author":"LA Levine","year":"2002","unstructured":"Levine LA, Goldman KE, Greenfield JM. Experience with intraplaque injection of verapamil for Peyronie\u2019s disease. J Urol 2002;168(2):621\u20135.","journal-title":"J Urol"},{"issue":"6","key":"1343_CR25","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.urology.2007.02.042","volume":"69","author":"NE Bennett","year":"2007","unstructured":"Bennett NE, Guhring P, Mulhall JP. Intralesional verapamil prevents the progression of Peyronie\u2019s disease. Urology 2007;69(6):1181\u20134.","journal-title":"Urology"},{"issue":"9","key":"1343_CR26","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/j.1464-410X.2010.10029.x","volume":"108","author":"DJ Moskovic","year":"2011","unstructured":"Moskovic DJ, Alex B, Choi JM, Nelson CJ, Mulhall JP. Defining predictors of presponse to intralesional verapamil injection therapy for Peyronie\u2019s disease. BJU Int 2011;108(9):1485\u20139.","journal-title":"BJU Int"},{"issue":"11","key":"1343_CR27","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1111\/j.1743-6109.2010.01924.x","volume":"7","author":"J Soh","year":"2010","unstructured":"Soh J, Kawauchi A, Kanemitsu N, Naya Y, Ochiai A, Naitoh Y, Fujwara T, Kamoi K, Miki T. Nicardipine vs. saline injection as treatment for Peyronie\u2019s disease: a prospective, randomized, single-blind trial. J Sex Med 2010;7(11):3743\u20139.","journal-title":"J Sex Med"},{"issue":"2","key":"1343_CR28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-5347(17)47123-0","volume":"124","author":"MK Gelbard","year":"1985","unstructured":"Gelbard MK, Lindner A, Kaufman JJ. The use of collagenase in the treatment of Peyronie\u2019s disease. J Urol 1985;124(2):280\u20133.","journal-title":"J Urol"},{"issue":"1","key":"1343_CR29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-5347(17)35998-0","volume":"149","author":"MK Gelbard","year":"1993","unstructured":"Gelbard MK, James K, Riach P, Dorey F. Collagenase versus placebo in the treatment of Peyronie\u2019s disease: a double-blind study. J Urol 1993;149(1):56\u20138.","journal-title":"J Urol"},{"issue":"1","key":"1343_CR30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1743-6109.2007.00651.x","volume":"5","author":"GH Jordan","year":"2008","unstructured":"Jordan GH. The use of intralesional clostridial collagenase injection therapy for Peyronie\u2019s disease: a prospective, single-center, non-placebo-controlled study. J Sex Med 2008;5(1):180\u20137.","journal-title":"J Sex Med"},{"key":"1343_CR31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00120-005-0988-0","volume":"45","author":"EW Hauck","year":"2006","unstructured":"Hauck EW, Diemer T, Weidner W. Induratio penis plastica. Urologe 2006;45:243\u201359.","journal-title":"Urologe"},{"issue":"6","key":"1343_CR32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11934-011-0212-2","volume":"12","author":"EC Serefoglu","year":"2011","unstructured":"Serefoglu EC, Hellstrom WJ. Treatment of Peyronie\u2019s disease: 2012 update. Curr Urol Rep 2011;12(6):444\u201352. Plastische, Hand- und Wiederherstellungschirurgie, Med. Hochschule Hannover","journal-title":"Curr Urol Rep"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-012-1343-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15006-012-1343-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-012-1343-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T02:26:37Z","timestamp":1714616797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-012-1343-1"}},"subtitle":["Morbus Peyronie"],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":32,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1343"],"URL":"https:\/\/doi.org\/10.1007\/s15006-012-1343-1","relation":{},"ISSN":["1438-3276"],"issn-type":[{"value":"1438-3276","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}